SeaStar Medical Completes Enrollment of SCD 005 Trial to Evaluate Safety of SCD in AKI and/or ARDS Patients with COVID-19
SeaStar Medical recently completed enrollment of its SCD-005 clinical trial to demonstrate the safety of Selective Cytopheretic Device (SCD) in acute kidney injury (AKI) and acute respiratory distress syndrome (ARDS) with COVID-19 infection. This...
A New Course for Fighting Inflammation
Hyperinflammation, or the cytokine storm, can be devastating to critically ill patients. Critical care professionals have long fought the effects of hyperinflammation in patients, and the COVID-19 pandemic has made knowledge of the cytokine storm...